HSBC Holdings’s Edwards Lifesciences EW Stock Holding History

HSBC Holdings’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.54M	Hold	57,200	–	–	﹤0.01%	1198
2025 Q4	$4.9M	Hold	57,200	–	–	﹤0.01%	1220
2025 Q3	$4.43M	Hold	57,200	–	–	﹤0.01%	1230
2025 Q2	$4.47M	Hold	57,200	–	–	﹤0.01%	1199
2025 Q1	$4.13M	Buy	57,200 +41,400	+262%	+$2.96M	﹤0.01%	1174
2024 Q4	$1.17M	Hold	15,800	–	–	﹤0.01%	1716
2024 Q3	$1.04M	Hold	15,800	–	–	﹤0.01%	1669
2024 Q2	$1.47M	Buy	+15,800	New	+$1.4M	﹤0.01%	1509
2021 Q2	–	Sell	-21,200	Closed	-$1.77M	–	2967
2021 Q1	$1.77M	Buy	21,200 +3,300	+18%	+$279K	﹤0.01%	1345
2020 Q4	$1.62M	Buy	17,900 +9,900	+124%	+$821K	﹤0.01%	1418
2020 Q3	$645K	Buy	+8,000	New	+$624K	﹤0.01%	1780
2020 Q1	–	Sell	-107,700	Closed	-$8.35M	–	2791
2019 Q4	$8.35M	Sell	107,700 -157,200	-59%	-$12.3M	0.01%	887
2019 Q3	$19.4M	Buy	264,900 +225,600	+574%	+$15.8M	0.04%	545
2019 Q2	$2.42M	Buy	+39,300	New	+$2.38M	﹤0.01%	1452
2019 Q1	–	Sell	-10,800	Closed	-$551K	–	2756
2018 Q4	$551K	Hold	10,800	–	–	﹤0.01%	2062
2018 Q3	$627K	Hold	10,800	–	–	﹤0.01%	1931
2018 Q2	$524K	Sell	10,800 -60,600	-85%	-$2.83M	﹤0.01%	2049
2018 Q1	$3.32M	Buy	+71,400	New	+$3.1M	﹤0.01%	1256

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HSBC Holdings's EW Position: Q1 2026 in Review

HSBC Holdings reduced its Edwards Lifesciences (EW) stake by 18% in Q1 2026, selling an estimated $31.2M and leaving 1,770,962 shares worth $142M. The position accounts for 0.07% of the portfolio, ranked #255.

HSBC Holdings first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $183M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

HSBC Holdings held 1,770,962 shares of Edwards Lifesciences worth $142M as of Q1 2026.
HSBC Holdings sold 378,012 Edwards Lifesciences shares in Q1 2026, an estimated $31.2M.
Edwards Lifesciences made up 0.07% of HSBC Holdings's portfolio in Q1 2026, its #255 holding.
HSBC Holdings first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
HSBC Holdings's Edwards Lifesciences position peaked at $183M in Q4 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.